Production (Stage)
Celularity Inc.
CELU
$1.76
$0.010.57%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 54.22M | 48.20M | 42.69M | 33.52M | 22.77M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 54.22M | 48.20M | 42.69M | 33.52M | 22.77M |
| Cost of Revenue | 14.99M | 17.26M | 16.97M | 15.65M | 16.02M |
| Gross Profit | 39.23M | 30.95M | 25.72M | 17.86M | 6.76M |
| SG&A Expenses | 58.64M | 55.65M | 53.75M | 50.67M | 50.58M |
| Depreciation & Amortization | 1.75M | 1.93M | 2.11M | 2.20M | 2.19M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 92.77M | 88.12M | 87.39M | 87.88M | 99.25M |
| Operating Income | -38.55M | -39.92M | -44.70M | -54.36M | -76.48M |
| Income Before Tax | -57.89M | -35.04M | -112.82M | -154.28M | -196.29M |
| Income Tax Expenses | -- | 10.00K | 10.00K | 10.00K | 10.00K |
| Earnings from Continuing Operations | -57.89 | -35.05 | -112.83 | -154.29 | -196.30 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -57.89M | -35.05M | -112.83M | -154.29M | -196.30M |
| EBIT | -38.55M | -39.92M | -44.70M | -54.36M | -76.48M |
| EBITDA | -30.63M | -31.58M | -35.91M | -45.24M | -67.16M |
| EPS Basic | -2.65 | -1.56 | -5.81 | -8.23 | -11.32 |
| Normalized Basic EPS | -1.54 | -0.82 | -0.73 | -1.42 | -2.98 |
| EPS Diluted | -2.65 | -1.56 | -5.81 | -8.23 | -11.32 |
| Normalized Diluted EPS | -1.54 | -0.82 | -0.73 | -1.42 | -2.98 |
| Average Basic Shares Outstanding | 87.56M | 84.46M | 81.31M | 77.12M | 71.22M |
| Average Diluted Shares Outstanding | 87.56M | 84.46M | 81.31M | 77.12M | 71.22M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |